<VariationArchive VariationID="1453372" VariationName="NM_198586.3(NHLRC1):c.799dup (p.Val267fs)" VariationType="Duplication" Accession="VCV001453372" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-17" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1428655" VariationID="1453372">
      <GeneList>
        <Gene Symbol="NHLRC1" FullName="NHL repeat containing E3 ubiquitin protein ligase 1" GeneID="378884" HGNC_ID="HGNC:21576" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="18120440" stop="18122677" display_start="18120440" display_stop="18122677" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="18120717" stop="18122850" display_start="18120717" display_stop="18122850" Strand="-" />
          </Location>
          <OMIM>608072</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198586.3(NHLRC1):c.799dup (p.Val267fs)</Name>
      <CanonicalSPDI>NC_000006.12:18121807:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6p22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="18121807" stop="18121808" display_start="18121807" display_stop="18121808" variantLength="1" positionVCF="18121807" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="18122038" stop="18122039" display_start="18122038" display_stop="18122039" variantLength="1" positionVCF="18122038" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>V267fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.18122042dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.18122042dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.18121811dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.18121811dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016750.1" sequenceAccession="NG_016750" sequenceVersion="1" change="g.5813dup">
            <Expression>NG_016750.1:g.5813dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198586.3" sequenceAccession="NM_198586" sequenceVersion="3" change="c.799dup" MANESelect="true">
            <Expression>NM_198586.3:c.799dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_940988.2" sequenceAccession="NP_940988" sequenceVersion="2" change="p.Val267fs">
            <Expression>NP_940988.2:p.Val267fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1362520746" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198586.3(NHLRC1):c.799dup (p.Val267fs) AND Lafora disease" Accession="RCV002002373" Version="5">
        <ClassifiedConditionList TraitSetID="792">
          <ClassifiedCondition DB="MedGen" ID="C0751783">Lafora disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="792" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3139" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lafora disease</ElementValue>
                <XRef ID="Lafora+disease/4074" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009697" DB="MONDO" />
                <XRef ID="230425004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lafora body disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myoclonic epilepsy of Lafora</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epilepsy progressive myoclonic  2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LBD</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM2</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MELF</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8214" />
                <XRef ID="8214" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Progressive myoclonus epilepsy, Lafora type (also known as Lafora disease [LD]) is characterized by focal occipital seizures presenting as transient blindness or visual hallucinations and fragmentary, symmetric, or generalized myoclonus beginning in previously healthy individuals at age eight to 19 years (peak 14-16 years). Generalized tonic-clonic seizures, atypical absence seizures, atonic seizures, and focal seizures with impaired awareness may occur. The course of the disease is characterized by increasing frequency and intractability of seizures. Status epilepticus with any of the seizure types is common. Cognitive decline becomes apparent at or soon after the onset of seizures. Dysarthria and ataxia appear early while spasticity appears late. Emotional disturbance and confusion are common in the early stages of the disease and are followed by dementia. Most affected individuals die within ten years of onset, usually from status epilepticus or from complications related to nervous system degeneration.</Attribute>
                <XRef ID="NBK1389" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301563</ID>
                <ID Source="BookShelf">NBK1389</ID>
              </Citation>
              <XRef ID="501" DB="Orphanet" />
              <XRef ID="C0751783" DB="MedGen" />
              <XRef ID="MONDO:0009697" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS254780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4252983" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13036661|MedGen:C0751783" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233308" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the NHLRC1 protein in which other variant(s) (p.Ser364*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1453372). This variant has not been reported in the literature in individuals affected with NHLRC1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Val267Glyfs*32) in the NHLRC1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 129 amino acid(s) of the NHLRC1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NHLRC1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.18122038_18122039insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751783" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4252983" TraitType="Disease" MappingType="XRef" MappingValue="C0751783" MappingRef="MedGen">
        <MedGen CUI="C0751783" Name="Lafora disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

